Press Releases Ypsomed Group

Burgdorf-based medical technology supplier Ypsomed, the leading independent developer and manufacturer of custom-made injection pens for pharmaceutical and biotech companies, and one of the leading suppliers of pen needles, is planning a listing on the Swiss Stock Exchange (SWX). After careful examination of a range of options to finance its rapid growth, the company has decided to go ahead with an Initial Public Offering (IPO) on the Swiss Stock Exchange. Further details of the listing should be available in the second week of September.

Go Back